# Johannes Gutenberg University Mainz

Organization · id `cardio:org-johannes-gutenberg-university-mainz` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 023b0x485](<https://ror.org/023b0x485>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 023b0x485 by an exact name.

## The registry's words

- Sponsor name: Johannes Gutenberg University Mainz
- Sponsor class: OTHER
- ROR name: Johannes Gutenberg University Mainz

## Connected pages

- Sponsors: Telmisartan, Amlodipine and Flow Mediated Dilation (`cardio:ct-nct01180205`)
- Sponsors: Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study (`cardio:ct-nct01700322`)
- Sponsors: A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach (`cardio:ct-nct02654353`)
- Sponsors: Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics (`cardio:ct-nct02932436`)
- Sponsors: RFR and FFR for the the Prediction of Post-PCI Results (`cardio:ct-nct04417634`)
- Sponsors: Pulmonary Embolism International THrOmbolysis Study-3 (`cardio:ct-nct04430569`)
- Sponsors: COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina (`cardio:ct-nct04606459`)
- Sponsors: QUantitative Flow Ratio Or Angiography for the assessMent of nOn-culprit Lesions (`cardio:ct-nct04808310`)
- Sponsors: Vagal Nerve Stimulation for the Treatment of Persistent AF (`cardio:ct-nct05833373`)
- Sponsors: Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients (`cardio:ct-nct06279793`)

## Provenance

Content hash: e4ad81cf0dcf38a1b8555fddafe7d0603f3fe25b10a0596667f73391cc92db44
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
